Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. XRN
XRN logo

XRN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Chiron Real Estate Inc (XRN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
33.820
1 Day change
0.83%
52 Week Range
37.810
Analysis Updated At
2026/04/24
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Chiron Real Estate Inc (XRN) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has a positive analyst rating and is exploring growth opportunities in senior housing, the financial performance shows significant losses, and the technical indicators are neutral. The lack of strong trading signals and recent news further supports a hold recommendation.

Technical Analysis

The MACD is positive but contracting, indicating a lack of strong momentum. RSI is neutral at 48.606, and moving averages are converging, suggesting no clear trend. Key support and resistance levels are close to the current price, with the pivot at 35.593, resistance at 36.345, and support at 34.841.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
8
Buy
1

Positive Catalysts

  • Analyst Gaurav Mehta raised the price target to $42, citing opportunities in senior housing with better returns. Gross margin remains high at 100%.

Neutral/Negative Catalysts

  • Net income has dropped significantly (-639.88% YoY), and EPS is negative (-0.55). No recent news or significant trading trends from insiders or hedge funds. No recent congress trading data available.

Financial Performance

In 2025/Q4, revenue increased by 9.20% YoY to $38,392,000. However, net income dropped to -$7,418,000, and EPS fell to -0.55. Gross margin remained stable at 100%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Alliance Global analyst Gaurav Mehta maintains a Buy rating and raised the price target to $42, citing growth opportunities in senior housing driven by favorable demographics and less supply.

Wall Street analysts forecast XRN stock price to rise
0 Analyst Rating
0
Wall Street analysts forecast XRN stock price to rise
0 Buy
0 Hold
0 Sell
0
Current: 33.540
sliders
Low
0
Averages
0
High
0
0
Current: 33.540
sliders
Low
0
Averages
0
High
0
Alliance Global
Buy
to
Buy
downgrade
$42 -> $40
AI Analysis
2026-05-07
New
Reason
Alliance Global
Price Target
$42 -> $40
AI Analysis
2026-05-07
New
downgrade
Buy
to
Buy
Reason
Alliance Global lowered the firm's price target on Chiron Real Estate to $40 from $42 and keeps a Buy rating on the shares. The firm updated the company's model post the Q1 report.
Compass Point
Merrill Ross
Buy
to
Neutral
downgrade
$50 -> $38
2026-05-07
New
Reason
Compass Point
Merrill Ross
Price Target
$50 -> $38
2026-05-07
New
downgrade
Buy
to
Neutral
Reason
Compass Point analyst Merrill Ross downgraded Chiron Real Estate to Neutral from Buy with a price target of $38, down from $50. The company has shifted from investing in a triple net lease portfolio comprised of single tenant outpatient medical offices to investing in senior housing operating properties, the analyst tells investors in a research note. The firm cites the company's transition and dividend cut for the downgrade.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for XRN
Unlock Now

People Also Watch